Search
Ravulizumab
go.drugbank.com/drugs/DB11580ApprovedInvestigationalRavulizumab is a potent and selective complement 5 (C5) inhibitor. It is a humanized monoclonal IgG2/4 kappa antibody produced in Chinese hamster ovary (CHO) cells. Ravulizumab was engineered from eculizumab, another complement inhibitor...
Urofollitropin
go.drugbank.com/drugs/DB00094ApprovedVet approvedWithdrawnUrofollitropin may also be used to cause the ovary to produce several follicles, which can then be harvested for use in gamete intrafallopian transfer (GIFT) or in vitro fertilization (IVF).
Products: FOSTİMON 75 IU ENJEKSİYONLUK LİYOFİLİZE TOZ, FOSTİMON 150 IU ENJEKSİYONLUK LİYOFİLİZE TOZClocortolone
go.drugbank.com/drugs/DB00838ApprovedClocortolone is a medium potency corticosteroid that is often used as a topical cream for the relief of inflammatory oand pruritic (itching) arising from steroid-responsive dermatoses of the scalp.
Sulbactam pivoxil
go.drugbank.com/drugs/DB15761InvestigationalMixtures: EUMOXIN DUO FORTE, EUMOXIN® DUO FORTENandrolone phenpropionate
go.drugbank.com/drugs/DB00984ApprovedIllicitC18 steroid with androgenic and anabolic properties. It is generally prepared from alkyl ethers of estradiol to resemble testosterone but less one carbon at the 19 position. It is a schedule III drug in the U.S.
CGX-1321
go.drugbank.com/drugs/DB17491InvestigationalCGX-1321 is a porcupine inhibitor that affects Wnt production and can block Wnt downstream signaling.[A257038]
Dihydromorphine
go.drugbank.com/drugs/DB01565ExperimentalIllicitA semisynthetic analgesic used in the study of narcotic receptors. It has abuse potential. [PubChem]
Propacetamol
go.drugbank.com/drugs/DB09288InvestigationalPropacetamol is a non-opioid analgesic devoid of the major contraindications. It is a derivative of acetaminophen, or paracetamol, with the molecular formula glycine, N, N-diethyl-,4-(acetylamino)phenyl ester. Propacetamol is a parentera...
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A InducersEP-1043
go.drugbank.com/drugs/DB06118ExperimentalEP-1043 is an epitope-based recombinant protein vaccine designed to induce HIV-1 specific helper T-lymphocyte (HTL) responses.